lISI
MEDICAL
AYEARTHATWASATURNING
POINT
FORMEDICALDEVICES
64
LISI 2013
I
namarket thatwas recovering slightly, 2013openedanew cycle for
theorthopedicworld, andmoregenerally for theworldofmedical
devices. Two reasons explain this structural change. The regulatory
steps taken followingserioushealth issues (PIP,all-metalprostheses
etc.), firstly, considerably tightened the technical requirements and
the verification levels applied toproducts and companies in the sector.
Thesenew technologicalbarriersbenefitedmedium-sizesubcontractors
and integratorssuchasLISIMEDICAL.
Stifferpressureonprices
More stringent global health policies have toughened price pressure
in the medical devices market. Most of the players, including LISI
MEDICAL, have opted to refocus their strategy and concentrate their
product lineonproven,mature and low-priceproduct families (suited
toemergingmarkets), involvinganacross theboard reduction inprices
in all segments. In 2013 these two items led tomajor concentration,
with a sharp increase inmergers and acquisitions, especially among
subassemblymanufacturers (OEM)andsubcontractors.
The tighteningof regulationshadastrong impact
on themarket in2013.Businesswas focusedon
subcontractorswhosescaleand technological
capabilitiesmerited investmentsandadaptation:
a favorablecontext forLISIMEDICAL.
